Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
Primary objective:To demonstrate the no-inferiority in efficacy of treatment with
Torsemide-PR in relation to Torsemide-IR in patients with mild and/or moderate hypertension.
Secondary objectives: To evaluate the safety and tolerability of Torsemide-PR.